Managing pharmaceutical costs continues to be a high priority for employers, and pharmacy benefit managers (PBMs) are facing increased scrutiny about their role in rising prescription drug costs and what many see as a broken, opaque pharmaceutical supply chain.

While some argue that legislation is required for reform, others in the private sector see a business opportunity to disrupt the industry and contribute to the value-based healthcare movement. Several innovative PBM startups are entering the market with greater price transparency at the core of their mission. Other innovations include alternative medication delivery systems, direct-to-consumer technology and fixed per-patient per-month fees.

Find out more.

See how rule of three’s strategic services can support you and your healthcare team.

How We Work